This Government Contract opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Manufacturing of Magnesium Sulfate Injection

Closed

Federal

Submission Closed05/26/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Self-Locking Hexagon Nuts

ASC COMMODITIES DIVISION

POSTED

DEADLINE

Supply of Centrifugal Brake Shoes (NSN 3040997213621)

LSO COMBAT VEHICLES AND ARMAMENT

POSTED

DEADLINE

SNS Pharmaceutical Logistic Replenishment Requirement

Solicitation # 75A50326R00007

The Department of Health and Human Services, through the Administration for Strategic Preparedness and Response, is soliciting proposals under solicitation 75A50326R00007 for the replenishment of expired or expiring pharmaceuticals for the Strategic National Stockpile. This is a full and open competition resulting in a twelve-month Firm Fixed Price contract. The scope includes the procurement of various FDA-approved pharmaceuticals, such as Dopamine Hydrochloride, Norepinephrine, and Morphine Sulfate, with the government reserving the right to increase awarded quantities by up to 20 percent. Deliveries are FOB Destination and may be required at up to nine locations across the contiguous United States and Hawaii. Award decisions will be based on a best-value tradeoff, prioritizing technical capability and past performance significantly over price. Technical evaluation focuses on product compliance, regulatory requirements, and the ability to meet delivery schedules. Strict quality standards are mandated, including adherence to current Good Manufacturing Practice regulations, specific temperature controls between 20C and 25C during storage and transit, and a requirement that products retain at least 90 percent of their FDA-approved shelf life upon receipt. Proposals must be submitted in two volumes by September 18, 2026, including a technical volume, a pricing volume, and a proposal submission worksheet. Large businesses are additionally required to submit subcontracting plans via the SBCX system.

POSTED

DEADLINE

Supply of Povidone-Iodine Topical Solution

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Fluconazole Tablets 150 MG

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine Hydrochloride Injection

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Close Tolerance Bolts (NSN 5306-01-049-4051)

ASC COMMODITIES DIVISION

POSTED

DEADLINE

Supply of Hydroxyzine Hydrochloride Tablets

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Socket Head Cap Screw Supplier

ASC COMMODITIES DIVISION

POSTED

DEADLINE

Supply of Globulin, Rho (D) Immune (USP)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Permethrin Cream Rinse Manufacturer

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Cefuroxime Axetil Tablets, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days

AI Contract Overview

The contract involves the manufacture of a sterile Magnesium Sulfate Injection, USP, precisely formulated as 2 grams of the heptahydrate form per 50mL vial. The production must adhere to the standards outlined by the United States Pharmacopeia (USP) and comply with current Good Manufacturing Practices (cGMP), ensuring the product's safety, quality, and efficacy. This is a subcontract opportunity posted by the Department of Defense under the Medical Supply Chain Pharm FSA, with the place of performance specified as Fort Bragg, ZIP code 28310. The solicitation was made available on May 18, 2026, with a response deadline of May 26, 2026. The contract falls under the NAICS code 325412, indicating pharmaceutical preparation manufacturing. No specific set aside applies, and further organizational or contact details were not provided. Interested parties can access the solicitation via the DLA’s DIBBS system using the provided link. This contract is critical to supporting medical supply needs, emphasizing compliance with stringent pharmaceutical manufacturing requirements.

General Info

Manufacture sterile Magnesium Sulfate Injection, USP, per cGMP and USP standards for DoD at Fort Bragg.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-3464.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

MAGNESIUM SULFATE I

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 18

subcontract

Response DeadlineMay 26

Deadline has passed

Submission Closed

05/26/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Manufacture of sterile Magnesium Sulfate Injection, USP, formulated as 2 grams (heptahydrate) per 50mL vial, compliant with USP standards and cGMP regulations.